Evidence map›Paper›PMID 40908668›Full record

ArticleActa oncologica (Stockholm, Sweden)2025

Image quality assessment of photon-counting CT for patients with prostate cancer receiving radiotherapy.

Cecilie Valet Henneberg, Weronika Elżbieta Olech, Louis Mathias Dreyer Teller, Gitte Fredberg Persson, Michael Brun Andersen, Felix Christoph Müller, Claus Preibisch Behrens, Henriette Klitgaard Mortensen, Vicki Trier Taasti, Stine Elleberg Petersen and 3 more

Abstract read
In one paragraph

Article in Acta oncologica (Stockholm, Sweden), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cecilie Valet HennebergDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark. cecilie.valet.henneberg@regionh.dk.ORCID 0009-0004-1856-6800
Weronika Elżbieta OlechDepartment of Radiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
Louis Mathias Dreyer TellerDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID 0009-0001-1966-2528
Gitte Fredberg PerssonDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-3363-3256
Michael Brun AndersenDepartment of Radiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-4886-5620
Felix Christoph MüllerDepartment of Radiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.ORCID 0000-0003-1051-8439
Claus Preibisch BehrensDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark.ORCID 0000-0002-0686-1421
Henriette Klitgaard MortensenDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
Vicki Trier TaastiDanish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-4588-9769
Stine Elleberg PetersenDanish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.ORCID 0009-0002-6516-6477
Henriette LindbergDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.ORCID 0000-0002-5191-3016
Vibeke LøgagerDepartment of Radiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.ORCID 0000-0001-5343-6869
Jens Morgenthaler EdmundDepartment of Oncology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.ORCID 0000-0001-5831-6209

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposePhoton-counting computed tomography (PCCT) offers enhanced image quality, including improvements in contrast, spatial resolution, and noise reduction. In radiotherapy (RT), optimal image quality is critical for accurate tumor and organ-at-risk delineation. However, reconstruction parameter selection often relies on subjective assessment. This study investigates whether quantitative image quality metrics, particularly contrast-to-noise ratio (CNR), can systematically guide PCCT reconstruction parameter optimization for prostate cancer RT planning. MATERIAL AND

methodsAn anthropomorphic abdomen phantom (QRM, Möhrendorf, Germany) and five patients with prostate cancer undergoing RT were scanned on a Naeotom Alpha PCCT (Siemens Healthineers, Forchheim, Germany). Reconstructions were performed across a range of kernel types, sharpness levels, and virtual monoenergetic image (VMI) energies, with the CNR calculated for each reconstruction. Additionally, a multidisciplinary expert panel qualitatively assessed a subset of reconstructions for two patients to compare with the quantitative findings.

resultsSofter kernels, particularly Br36 and Qr36, combined with lower VMI energies of 40 keV, consistently produced the highest CNR values in both phantom and patient datasets. The qualitative assessment generally supported the quantitative results, with minor deviations likely reflecting the experts' preference for a more familiar image appearance.

interpretationQuantitative metrics such as CNR can reliably identify optimal PCCT reconstruction settings for prostate cancer RT, favoring lower VMI energies and softer reconstruction kernels. These findings were consistent across phantom and patient data and were supported by expert evaluations, indicating that a quantitative approach can effectively guide protocol development and reduce reliance on subjective image assessment.

Indexed as

Prostatic NeoplasmsRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedHumansMaleOrgans at RiskPhantoms, ImagingPhotonsSignal-To-Noise Ratio

Identifiers

PMID40908668
PMCPMC12453146

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.